Neurodegeneration – News and Features

New findings published in leading science journals, Nature Genetics and Lancet Neurology.

This announcement builds upon PerkinElmer's recent acquisition of Evotec Technologies, a provider of high-performance cellular screening systems.

A multi-million pound visionary medical project that will recruit 500,000 people across Britain to help find out much more about curing many life threatening and debilitating diseases gets underway in Manchester.

The new subsidary joins Arrowhead as its third focused on nanomedicine.

The Pennsylvania center will represent NeoStem’s strategic plan to generate revenues from nationwide network targeting projected $8.5 billion market.

Millipore has acquired an exclusive worldwide license to distribute the ENStem neural progenitor cells derived from NIH-registered human embryonic stem cells.

A research study in mice at Rockfeller University shows that embryonic stem cells implanted in the brain appear to develop into fully differentiated granule neurons.

Both companies have signed a multi-year collaboration to jointly identify targets for the treatment of Alzheimer’s disease with the Research Institute of Molecular Pathology in Vienna.

Stem cell study led by the Burnham Institute researchers proves to be the first successful use of human embryonic stem cells in treating a degenerative disease.

According to Company, the center will be among the world’s first facilities to offer the processing and storing of adult stem cells for an adult’s own therapeutic use.